A patient with osteomyelitis caused by MRSA is experiencing increased pain and swelling in the affected limb despite being on intravenous vancomycin. What is the most appropriate nursing action?

B) Notify the healthcare provider about the possibility of antibiotic resistance.

A) Administer additional analgesics as prescribed and reassess pain levels.

B) Notify the healthcare provider about the possibility of antibiotic resistance.

C) Encourage the patient to ambulate to improve circulation to the affected area.

D) Apply warm compresses to the affected area to reduce swelling.

A patient with diabetes and peripheral vascular disease has been diagnosed with osteomyelitis caused by MRSA. Which nursing intervention is most critical to include in the care plan to prevent further complications?

C) Assess for signs of nephrotoxicity while administering intravenous vancomycin

A) Monitor blood glucose levels regularly and adjust insulin as needed

B) Encourage increased fluid intake to prevent dehydration

C) Assess for signs of nephrotoxicity while administering intravenous vancomycin

D) Educate the patient on foot care to prevent further infections

A patient with osteomyelitis on vancomycin therapy shows signs of acute kidney injury. Which nursing intervention should be prioritized to address this change in condition?

B) Increase the patient's fluid intake to enhance renal perfusion and support kidney function.

A) Administer an additional dose of vancomycin to ensure therapeutic levels.

B) Increase the patient's fluid intake to enhance renal perfusion and support kidney function.

C) Initiate high-protein diet to promote healing and support nutritional needs.

D) Prepare the patient for dialysis as the first-line treatment for acute kidney injury.

A patient receiving vancomycin therapy for MRSA osteomyelitis shows signs of acute kidney injury, with a rise in creatinine level and decreased urine output. Which nursing intervention is the most appropriate to prioritize in this situation?

B) Hold the vancomycin and monitor renal function closely.

A) Increase the patient's oral fluid intake to improve hydration.

B) Hold the vancomycin and monitor renal function closely.

C) Administer furosemide to increase urine output.

D) Provide the patient with acetaminophen for the mild fever.

A patient with acute kidney injury is experiencing mild bilateral hydronephrosis and hyperkalemia with a potassium level of 5.9 mEq/L. The healthcare team is considering the initiation of calcium gluconate. What is the primary reason for administering calcium gluconate in this scenario?

B) To protect the heart from the effects of elevated potassium levels

A) To directly lower the potassium level in the blood

B) To protect the heart from the effects of elevated potassium levels

C) To improve renal function by reducing fluid retention

D) To increase serum calcium levels to normal range

A patient with acute kidney injury presents with mild bilateral hydronephrosis, hyperkalemia, and decreased hemoglobin levels. Which nursing intervention is most appropriate to prioritize in this situation?

A) Administer calcium gluconate as ordered to stabilize cardiac membranes.

B) Encourage a high-protein diet to prevent muscle wasting.

C) Start an intravenous fluid bolus to improve renal perfusion.

D) Initiate high-flow oxygen therapy to address potential anemia-related hypoxia.

A patient has been diagnosed with worsening hyperkalemia and is exhibiting symptoms such as fatigue, muscle weakness, confusion, and mild tremors. The healthcare team has initiated treatment with calcium gluconate, insulin, and glucose. Which additional intervention should the nurse prioritize to help manage the patient's hyperkalemia and prevent cardiac complications?

C) Administer sodium polystyrene sulfonate to enhance potassium elimination through the gastrointestinal tract.

A) Administer a loop diuretic to promote renal excretion of potassium.

B) Prepare the patient for dialysis to rapidly decrease potassium levels.

C) Administer sodium polystyrene sulfonate to enhance potassium elimination through the gastrointestinal tract.

D) Increase the patient's dietary intake of calcium to counteract the low calcium levels.

A patient with worsening hyperkalemia and anemia presents with increased fatigue, muscle weakness, occasional confusion, and mild tremors. Her current treatment includes calcium gluconate, insulin and glucose therapy, and considerations for sodium polystyrene sulfonate and blood transfusion. Which nursing intervention is most crucial to prioritize at this time?

A) Monitor the patient's cardiac rhythm closely for signs of arrhythmias.

C) Prepare for immediate blood transfusion to address anemia.

D) Educate the patient on the importance of dietary potassium restriction.

A 67-year-old female with a history of chronic kidney disease and osteomyelitis is experiencing persistent hyperkalemia, lethargy, and confusion despite treatment with calcium gluconate, insulin, and glucose therapy. The healthcare team has initiated hemodialysis and a unit of packed red blood cells has been transfused. Which nursing intervention is a priority to ensure patient safety during this acute phase?

B) Assess the patient's neurological status hourly to monitor for changes in mental status.

A) Monitor blood pressure every 30 minutes to detect hypotension during hemodialysis.

B) Assess the patient's neurological status hourly to monitor for changes in mental status.

C) Strictly monitor intake and output to prevent fluid overload due to renal impairment.

D) Educate the patient about the purpose and side effects of hemodialysis and blood transfusion.

A patient presents with hyperkalemia and altered mental status despite treatment interventions. Which action should the nurse prioritize to address the patient's current condition?

B) Prepare the patient for immediate hemodialysis.

A) Increase the infusion rate of calcium gluconate.

B) Prepare the patient for immediate hemodialysis.

C) Administer an additional dose of insulin and glucose.

D) Request a neurology consult for altered mental status.

Osteomyelitis - Nursing Case Study

Pathophysiology

• Primary mechanism: Osteomyelitis typically begins with the invasion of bone tissue by pathogenic bacteria, most commonly Staphylococcus aureus, leading to an acute inflammatory response. These bacteria can reach the bone via the bloodstream, direct inoculation from trauma or surgery, or contiguous spread from nearby infections.

• Secondary mechanism: The inflammatory response results in increased pressure within the bone due to edema, which compromises blood flow and leads to ischemia. This reduced blood supply hinders immune cell access and nutrient delivery, allowing the infection to persist and worsen.

• Key complication: As the infection progresses, necrosis of bone tissue (sequestrum) can occur, which serves as a reservoir for persistent infection. This can lead to chronic osteomyelitis, characterized by ongoing inflammation, bone destruction, and potential for systemic spread if not adequately treated.

Patient Profile

Demographics:

45 years old, female, school teacher

History:

• Key past medical history: Type 2 Diabetes Mellitus, Hypertension

• Current medications: Metformin, Lisinopril, Ibuprofen

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe pain and swelling in the lower left leg

• Key symptoms: Fever, chills, night sweats, redness and warmth over the affected area, difficulty bearing weight on the left leg

• Vital signs: Temperature 101.3°F, Heart Rate 110 bpm, Blood Pressure 150/95 mmHg, Respiratory Rate 22 breaths per minute

Section 1

New Diagnostic Results:

As the diagnostic workup progresses, the healthcare team receives crucial laboratory and imaging results that further elucidate the severity of the patient’s osteomyelitis and guide the next steps in management. Blood cultures confirm the presence of methicillin-resistant Staphylococcus aureus (MRSA), necessitating a change in antibiotic therapy due to the patient's penicillin allergy. Additionally, inflammatory markers such as ESR and CRP are significantly elevated, underscoring the active infectious and inflammatory process.

Imaging studies, including an MRI of the lower left leg, reveal extensive bone marrow edema and a clear area of sequestrum within the tibia. The MRI findings indicate both acute and chronic changes, suggesting that the infection has been ongoing for some time, likely exacerbated by the patient's underlying diabetes and peripheral vascular disease. These results highlight the need for aggressive treatment to prevent further complications, such as systemic spread or limb-threatening ischemia.

These diagnostic insights prompt the healthcare team to reassess the current treatment plan. The patient is started on intravenous vancomycin to address the MRSA infection, with careful monitoring required due to potential nephrotoxicity given her existing hypertension. The team also considers surgical intervention to remove the sequestrum and debride necrotic tissue, which is critical to halting the progression of the infection. This comprehensive approach aims to stabilize the patient’s condition, improve her pain and swelling, and ultimately preserve limb function, while also addressing systemic control of her diabetes and hypertension to support healing.

Section 2

Change in Patient Status

Following the initiation of intravenous vancomycin therapy, the patient initially shows promising signs of improvement, with a slight reduction in pain and swelling in the affected leg. However, within 48 hours, the healthcare team observes a concerning change in her status. The patient begins to exhibit signs of acute kidney injury, as evidenced by a rising creatinine level, now at 2.1 mg/dL from a baseline of 1.0 mg/dL, and reduced urine output falling to 25 mL/hr. Additionally, she complains of increasing fatigue and mild confusion, prompting a thorough reassessment of her fluid status and medication regimen.

Vital signs reveal a blood pressure of 150/90 mmHg, heart rate of 92 bpm, temperature of 99.5°F, and oxygen saturation of 95% on room air. The elevated blood pressure, coupled with the renal function decline, suggests possible nephrotoxicity from the vancomycin or worsening of her underlying hypertensive condition, requiring immediate attention. The healthcare team decides to hold the vancomycin and consult nephrology to manage the renal impairment while considering alternative antibiotics to continue addressing the MRSA infection. Additionally, the team initiates fluid optimization and carefully monitors her electrolyte balance, recognizing the delicate interplay between her diabetes, hypertension, and current infection.

This change highlights the complexity of managing osteomyelitis in a patient with multiple comorbidities, emphasizing the need for ongoing clinical reasoning and adaptation of the treatment plan. The situation prompts further investigations, such as daily renal function tests and consideration of renal-supportive therapies, to stabilize her condition and prevent further complications. The team remains vigilant in balancing aggressive infection control with the preservation of renal function, aiming to guide the patient safely through this critical phase of her treatment journey.

Section 3

New Diagnostic Results

Following the nephrology consultation, the healthcare team decides to proceed with a renal ultrasound and additional blood tests to further investigate the cause of the acute kidney injury and assess the extent of renal involvement. The ultrasound reveals mild bilateral hydronephrosis, suggesting possible obstruction or significant fluid retention, which could be contributing to the reduced urine output. Further blood tests indicate a significant rise in potassium levels, now at 5.9 mEq/L, and a slight decrease in calcium, at 8.4 mg/dL. These electrolyte imbalances raise concerns about the potential for cardiac complications and necessitate immediate corrective measures.

The team also reviews the latest complete blood count and metabolic panel. White blood cell count remains elevated at 14,000/mm³, indicating ongoing infection or inflammation, but hemoglobin levels have decreased to 10.5 g/dL, suggesting the need to monitor for anemia, potentially exacerbated by renal impairment. The C-reactive protein level remains high, aligning with the persistent inflammatory response. These diagnostic results prompt the healthcare team to reassess the current treatment plan, taking into account the patient's altered renal function and electrolyte disturbances.

Given the complexity of her condition, the team decides to adjust her antihypertensive medication regimen to better manage her blood pressure without further compromising renal function. They initiate a low-dose diuretic to address the fluid retention cautiously and consider the introduction of calcium gluconate to counteract hyperkalemia. At the same time, they emphasize the importance of maintaining nutritional support, focusing on a diet that balances protein intake while avoiding excess potassium and phosphorus. These diagnostic insights contribute critically to refining her management plan, setting the stage for the next steps in her care while preventing further complications.

Section 4

New Complications

As the healthcare team continues to monitor the patient, they notice a change in her condition. Over the next 48 hours, despite the adjusted treatment plan, the patient begins to exhibit new symptoms. She reports increased fatigue and muscle weakness, and nurses observe occasional episodes of confusion and mild tremors. Her vital signs show a blood pressure of 138/92 mmHg, heart rate of 102 beats per minute, and respiratory rate of 20 breaths per minute. Her temperature remains slightly elevated at 37.8°C (100°F). These new clinical manifestations raise concerns about the progression of her underlying condition and the potential development of additional complications.

Subsequent laboratory tests reveal a further increase in potassium levels to 6.3 mEq/L, indicating worsening hyperkalemia despite initial treatment efforts. The calcium level has declined slightly to 8.1 mg/dL, while her hemoglobin has dropped to 9.8 g/dL, suggesting worsening anemia. Serum creatinine and blood urea nitrogen levels remain elevated, reflecting ongoing renal impairment. Electrocardiogram readings are performed in light of the elevated potassium levels and reveal peaked T-waves, heightening the concern for cardiac arrhythmias.

These findings prompt the healthcare team to reevaluate her current management strategy. They decide to increase the dosage of calcium gluconate to stabilize her cardiac membrane potential and begin insulin and glucose therapy to help lower serum potassium levels promptly. The team also considers the addition of a sodium polystyrene sulfonate to facilitate potassium excretion. Given her declining hemoglobin levels, a blood transfusion is contemplated to address her anemia, with careful consideration of her fluid status and renal function. The healthcare team emphasizes the importance of close monitoring of her cardiac status, renal function, and electrolytes as they implement these interventions, aiming to stabilize her condition and prevent further deterioration.

Section 5

Change in Patient Status

In the ensuing 24 hours, the patient's condition takes a concerning turn. Despite the administration of calcium gluconate, insulin, and glucose therapy, her potassium levels remain elevated at 6.1 mEq/L, showing only a marginal decrease. Her heart rate has increased to 110 beats per minute, and she is experiencing more frequent episodes of confusion, accompanied by a pronounced hand tremor. The nursing staff notes that the patient appears increasingly lethargic and is having difficulty maintaining consciousness during routine assessments. Her blood pressure has risen to 142/94 mmHg, and her respiratory rate has slightly elevated to 22 breaths per minute. Though her temperature remains stable at 37.8°C (100°F), the team is concerned about the potential for further cardiovascular complications.

Given these developments, the healthcare team prioritizes continuous cardiac monitoring, recognizing the risk of arrhythmias due to persistent hyperkalemia. The decision is made to initiate hemodialysis as a more aggressive measure to manage electrolyte imbalances and support her compromised renal function. Additionally, due to her progressive lethargy and anemia, a unit of packed red blood cells is transfused, with careful monitoring of her fluid balance to mitigate any potential overload, considering her renal impairment.

In light of her deteriorating mental status and increased confusion, a neurological assessment is performed to rule out any central nervous system complications. These changes prompt the team to reassess potential underlying causes, including the efficacy of antimicrobial therapy in controlling the osteomyelitis, and consider additional imaging to evaluate for any occult abscesses or further spread of infection. The team remains vigilant, responding dynamically to her evolving clinical needs, while continuing to reassess her treatment plan to ensure the most comprehensive care.